In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines.
about
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer.Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinomaDown-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells.Cross-contamination of a UROtsa stock with T24 cells--molecular comparison of different cell lines and stocksCyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effectsMiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.Inhibition of cancer cell epithelial mesenchymal transition by normal fibroblasts via production of 5-methoxytryptophan.Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.Animal models of urinary bladder cancer and their application to novel drug discovery.New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2.Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer.Expression and clinical implication of cyclooxygenase-2 and e-cadherin in oral squamous cell carcinomas.Preventive effect of celecoxib use against cancer progression and occurrence of oral squamous cell carcinoma.Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma MetastasisThe Role of Epithelial to Mesenchymal Transition in Human Amniotic Membrane Rupture.Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial.MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2.Understanding the biology of urothelial cancer metastasis.The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancerInfection Disrupts Adherens Junctions and Initializes EMT Dependent on Canonical Wnt/β-Catenin Signaling Pathway
P2860
Q33640357-00CA1EAD-0461-4ABF-B1C5-6B0B2843BD9CQ33646333-9BC869B4-A5AE-4ED8-82D6-976C4809938CQ34206376-36F7B6F6-40E9-4770-B98F-95D6B7AF4D65Q34731286-137559A4-7475-496E-A202-4BCF7B4FA85DQ35838020-D2035983-44F5-4BCF-A41D-6FF24D5EA03BQ36561589-55E2951F-2FEB-4763-8C86-40E5FE2C6D58Q36924812-23084AB1-D306-49D4-A5F8-3394CD0E125EQ37046835-6CFED1CD-8B98-4CD8-8A07-FBCFA5A0565DQ37327720-40C7EB4F-8840-4EB7-B799-F4D371D67921Q37636784-D44E255E-7B07-4AC2-84C7-F2CD32A3C49AQ38199547-2916E7FC-35EF-40B9-BCC4-28084D1A81C3Q38550876-1DACA407-30E2-4A9F-994E-706612656264Q39016583-1C884904-7D25-480C-81EB-B5CD2F3F45D8Q39373562-5B4EE6C1-A680-4AB7-8F34-44EB9668CB10Q40686914-C7B2EAD1-9965-42C8-9B36-AE905220CF4BQ41109724-0F8408FC-25A4-4564-981B-C2381E464D13Q42731074-695CEAD1-0FE9-44DE-AB24-DA31302A74CBQ46501486-389D644C-7A4C-4570-B184-91FBB3D4F68EQ46520435-20CA354B-6980-4659-8594-B97F1FFA6688Q49875103-F822AC96-41F6-4AAE-B2B4-72F4DC06EF1EQ55126311-159CE0B9-A059-4ACD-9836-1E24C0A28CFBQ57088778-C12A0418-5C02-4F87-9F37-E3B5102251D9Q58746591-D1B58571-5060-455D-BABA-E89EC3A27593
P2860
In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
In vitro and in vivo inhibitor ...... man bladder cancer cell lines.
@ast
In vitro and in vivo inhibitor ...... man bladder cancer cell lines.
@en
type
label
In vitro and in vivo inhibitor ...... man bladder cancer cell lines.
@ast
In vitro and in vivo inhibitor ...... man bladder cancer cell lines.
@en
prefLabel
In vitro and in vivo inhibitor ...... man bladder cancer cell lines.
@ast
In vitro and in vivo inhibitor ...... man bladder cancer cell lines.
@en
P2093
P2860
P356
P1476
In vitro and in vivo inhibitor ...... uman bladder cancer cell lines
@en
P2093
K Shigemura
M Fujisawa
M Kawabata
T Matsuoka
P2860
P2888
P304
P356
10.1038/BJC.2011.262
P407
P577
2011-07-12T00:00:00Z